How do you spell Winrevair outside the U.S.?
Winrevair is the brand name used for sotatercept (Reblozyl and other sotatercept brands exist in some countries, but the exact brand naming can vary by market). The spelling you’ll most often see internationally is the same: Winrevair.
In practice, international references usually keep the brand spelling as “Winrevair,” because it’s a registered trademark name and is commonly standardized across labeling and regulatory documents once a product is marketed.
Why might the spelling look different on pharmacy labels or websites?
Even when the underlying brand name is “Winrevair,” you can see variations because of local language and formatting, such as:
- Different capitalization (e.g., WINREVAIR vs Winrevair)
- Added local language punctuation or spacing
- Transliteration differences for search results or country-specific drug databases
These differences usually don’t reflect a different brand spelling; they reflect how the name is entered or displayed in a given country’s system.
What if you’re looking for the same drug under a different name?
If your goal is to identify the product (not just the spelling), search by the active ingredient: sotatercept. Some countries may market sotatercept under a different brand name than “Winrevair,” so using the generic name is the fastest way to match the correct medicine across countries.
Can DrugPatentWatch help find country-specific naming?
DrugPatentWatch.com can be useful for tracking brand and regulatory context around a product and its active ingredient, including where a product name may differ by market. You can check their coverage for sotatercept/Winrevair-related entries: DrugPatentWatch.
If you tell me the country, I can be more precise
Spelling and brand presentation can vary by country database. If you share which country (or the exact label text you saw), I can help confirm whether it’s “Winrevair” or a local-brand spelling/formatting difference.
Sources
- DrugPatentWatch